196 related articles for article (PubMed ID: 9508167)
1. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.
Blay JY; Conroy T; Chevreau C; Thyss A; Quesnel N; Eghbali H; Bouabdallah R; Coiffier B; Wagner JP; Le Mevel A; Dramais-Marcel D; Baumelou E; Chauvin F; Biron P
J Clin Oncol; 1998 Mar; 16(3):864-71. PubMed ID: 9508167
[TBL] [Abstract][Full Text] [Related]
2. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
[TBL] [Abstract][Full Text] [Related]
5. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma.
O'Brien P; Roos D; Pratt G; Liew K; Barton M; Poulsen M; Olver I; Trotter G
J Clin Oncol; 2000 Feb; 18(3):519-26. PubMed ID: 10653867
[TBL] [Abstract][Full Text] [Related]
6. The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression.
Blay JY; Bouhour D; Carrie C; Bouffet E; Brunat-Mentigny M; Philip T; Biron P
Blood; 1995 Oct; 86(8):2922-9. PubMed ID: 7579384
[TBL] [Abstract][Full Text] [Related]
7. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas.
Hiraga S; Arita N; Ohnishi T; Kohmura E; Yamamoto K; Oku Y; Taki T; Sato M; Aozasa K; Yoshimine T
J Neurosurg; 1999 Aug; 91(2):221-30. PubMed ID: 10433310
[TBL] [Abstract][Full Text] [Related]
8. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
Singhal D; Witham TF; Germanwala A; Flickinger JC; Schiff D; Kondziolka D
Can J Neurol Sci; 2002 May; 29(2):147-53. PubMed ID: 12035835
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
DeAngelis LM; Seiferheld W; Schold SC; Fisher B; Schultz CJ;
J Clin Oncol; 2002 Dec; 20(24):4643-8. PubMed ID: 12488408
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma: a single-centre experience of 55 unselected cases.
Hodson DJ; Bowles KM; Cooke LJ; Kläger SL; Powell GA; Laing RJ; Grant JW; Williams MV; Burnet NG; Marcus RE
Clin Oncol (R Coll Radiol); 2005 May; 17(3):185-91. PubMed ID: 15901003
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
12. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
13. [Primitif cerebral lymphoma].
Benouaich-Amiel A; Kaloshi G; Khe HX
Rev Prat; 2006 Oct; 56(16):1787-91. PubMed ID: 17315504
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
Kiewe P; Fischer L; Martus P; Thiel E; Korfel A
Cancer; 2008 Apr; 112(8):1812-20. PubMed ID: 18318432
[TBL] [Abstract][Full Text] [Related]
16. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
Fliessbach K; Urbach H; Helmstaedter C; Pels H; Glasmacher A; Kraus JA; Klockgether T; Schmidt-Wolf I; Schlegel U
Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070
[TBL] [Abstract][Full Text] [Related]
17. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.
Batchelor T; Carson K; O'Neill A; Grossman SA; Alavi J; New P; Hochberg F; Priet R
J Clin Oncol; 2003 Mar; 21(6):1044-9. PubMed ID: 12637469
[TBL] [Abstract][Full Text] [Related]
18. Improved survival with combined chemo-radiotherapy in primary central nervous system lymphoma.
Abdelsalam M; El-Husseiny G; Akhtar S; Khafaga Y; Al-Shabana M; AlHusaini H; El Weshi A; Rahal M; Maghfoor I
Hematol Oncol Stem Cell Ther; 2010; 3(3):128-34. PubMed ID: 20890070
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system lymphoma in Japan: a nationwide survey.
Hayabuchi N; Shibamoto Y; Onizuka Y
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):265-72. PubMed ID: 10760418
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.
Korfel A; Thiel E; Martus P; Möhle R; Griesinger F; Rauch M; Röth A; Hertenstein B; Fischer T; Hundsberger T; Mergenthaler HG; Junghanß C; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Roth P; Bamberg M; Pietsch T; Weller M
Neurology; 2015 Mar; 84(12):1242-8. PubMed ID: 25716362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
